<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01961895</url>
  </required_header>
  <id_info>
    <org_study_id>Altermatt 09-148</org_study_id>
    <nct_id>NCT01961895</nct_id>
  </id_info>
  <brief_title>Lumbar Plexus Block Upon the Incidence of Ischemic Cardiovascular Events in Elderly Patients With Hip Fracture</brief_title>
  <official_title>Evaluation of the Effect of Perioperative Continuous Lumbar Plexus Block Upon the Incidence of Ischemic Cardiovascular Events in Elderly Patients With Hip Fracture.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pontificia Universidad Catolica de Chile</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pontificia Universidad Catolica de Chile</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is evaluate the efficacy of perioperative continuous lumbar plexus
      block in reducing the risk of cardiac ischemic events of elderly patients undergoing surgery
      for hip fractures, expressed as a reduction of ischemic events per subject.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2010</start_date>
  <primary_completion_date type="Actual">May 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>evaluate the efficacy of perioperative continuous lumbar plexus block in reducing the risk of cardiac ischemic events of elderly patients undergoing surgery for hip fractures, expressed as a reduction of ischemic events per subject.</measure>
    <time_frame>3 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Major cardiovascular events (myocardial infarction, acute pulmonary edema, arrhythmias).</measure>
    <time_frame>3 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hospital death</measure>
    <time_frame>3 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Death at 30, 90 and 360 days after surgery</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Perioperative Pain Intensity, measured in numerical rating scale (NRS).</measure>
    <time_frame>3 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluate Adverse events (hypotension, respiratory depression, systemic toxicity, etc..)</measure>
    <time_frame>3 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">31</enrollment>
  <condition>Hip Fractures</condition>
  <condition>Perioperative Myocardial Ischemia</condition>
  <arm_group>
    <arm_group_label>Intravenous patient-controlled analgesia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intravenous morphine solution 0.2 mg / ml in PCA mode without basal infusion, 1mg bolus demand and lockout of 8 minutes.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Continuous lumbar plexus (LP) block analgesia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Continuous lumbar plexus (LP) block analgesia. Continuous infusion of a solution of 0.1% bupivacaine in PCA mode, programmed at 8 ml / h.
Rescue bolus 5 ml and 30 minutes lockout</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Continuous lumbar plexus (LP) block analgesia</intervention_name>
    <arm_group_label>Continuous lumbar plexus (LP) block analgesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intravenous patient-controlled analgesia</intervention_name>
    <arm_group_label>Intravenous patient-controlled analgesia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with hip fracture within 48 hours of evolution

          -  Known coronary artery disease:

        Previous myocardial infarction Chronic stable angina Atypical angina with positive exercise
        test for coronary flow failure. Evidence of coronary artery disease with ultrasound,
        scintigraphic or angiographic compatible

          -  Patients with at least two of the risk factors for coronary heart disease as defined
             by Wallace (1998)

        Exclusion Criteria:

          -  Patients receiving orthopedic treatment.

          -  Patients with coagulopathy, clinic or laboratory.

          -  Patients with sepsis or infection of the catheter insertion site of lumbar plexus.

          -  Patients with neurological diseases evolving.

          -  Patients disoriented, or dementia.

          -  CKD stage IV National Kidney Foundation (2)

          -  Glomerular filtration rate between 15 and 29 mL/min/1, 73 m2

          -  Patients unable to use the Numeric Rating Scale (NRS) to assess pain.

          -  Patients with non-sinus rhythm or conduction abnormalities (right bundle branch block
             or left, atrioventricular block) in the admission ECG

          -  Patients with pacemaker.

          -  Enrolled patients with acute coronary syndrome or decompensated cardiovascular disease
             at entry.

          -  Allergy to any of the drugs of the protocol.

          -  Inability to understand or unaided sign informed consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Division de Anestesia - Pontificia Universidad Catolica de Chile</name>
      <address>
        <city>Santiago</city>
        <state>Region Metropolitana</state>
        <zip>8330024</zip>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>División de Anestesia - Facultad de Medicina Pontificia Universidad Católica</name>
      <address>
        <city>Santiago</city>
        <state>Región Metropolitana</state>
        <zip>8330024</zip>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Chile</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 10, 2013</study_first_submitted>
  <study_first_submitted_qc>October 11, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 14, 2013</study_first_posted>
  <last_update_submitted>October 11, 2013</last_update_submitted>
  <last_update_submitted_qc>October 11, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 14, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Continuous lumbar plexus (LP) block analgesia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fractures, Bone</mesh_term>
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Hip Fractures</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

